YF-476   Click here for help

GtoPdb Ligand ID: 887

Synonyms: YF 476 | YF476
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 115.79
Molecular weight 498.24
XLogP 2.66
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNc1cccc(c1)NC(=O)NC1N=C(c2ccccn2)c2c(N(C1=O)CC(=O)C(C)(C)C)cccc2
Isomeric SMILES CNc1cccc(c1)NC(=O)N[C@@H]1N=C(c2ccccn2)c2c(N(C1=O)CC(=O)C(C)(C)C)cccc2
InChI InChI=1S/C28H30N6O3/c1-28(2,3)23(35)17-34-22-14-6-5-12-20(22)24(21-13-7-8-15-30-21)32-25(26(34)36)33-27(37)31-19-11-9-10-18(16-19)29-4/h5-16,25,29H,17H2,1-4H3,(H2,31,33,37)/t25-/m0/s1
InChI Key YDZYKNJZCVIKPP-VWLOTQADSA-N
References
1. Boyce M, David O, Darwin K, Mitchell T, Johnston A, Warrington S. (2012)
Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects.
Aliment Pharmacol Ther, 36 (2): 181-9. [PMID:22607579]
2. Nilsson I, Monstein HJ, Lindström E, Håkanson R, Svensson S. (2002)
Pharmacological analysis of CCK(2) receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK(2) receptor.
Regul Pept, 103 (1): 29-37. [PMID:11738246]
3. Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S et al.. (1997)
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
J Med Chem, 40 (3): 331-41. [PMID:9022799]
4. Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K. (1997)
YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
Aliment Pharmacol Ther, 11 (1): 113-20. [PMID:9042983]